Quinn Opportunity Partners LLC
Position in SPRB — Spruce Biosciences, Inc.
CIK 1633275
CHARLOTTESVILLE, VA
Position in SPRB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,752,033
-$234,946 QoQ
Shares Held
26,810
+17.5% QoQ
Ownership
0.974%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in SPRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Quinn Opportunity Partners LLC holds $55,803,564 across 25 Biotechnology names. SPRB ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BNTX |
BioNTech SE
|
228,832 | $20,338,588 | |
| 2 | NKTR |
Nektar Therapeutics
|
179,247 | $12,896,821 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
178,383 | $5,422,843 | |
| 4 | ABUS |
Arbutus Biopharma Corp
|
514,513 | $2,315,308 | |
| 5 | REPL |
Replimune Group, Inc.
|
287,795 | $2,201,631 | |
| 6 | ABVX |
Abivax S.A.
|
16,000 | $1,781,600 | |
| 7 | SPRB |
Spruce Biosciences, Inc.
This page
|
26,810 | $1,752,033 | |
| 8 | SPRY |
ARS Pharmaceuticals, Inc.
|
155,000 | $1,244,650 |
All Filings in SPRB
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,752,033 | 26,810 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,986,979 | 22,810 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||